NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/19/2024
Back to search
Official data from USPTO
ENDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/03/2025
Trademark type
Combined
Nice classes
5, 18
Filing date
01/22/1935
Registration date
06/04/1935
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2024
Last transaction
04/03/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/01/1916
First use in commerce
06/01/1916
Drawing code
5
Owner type
24
Owner location
BALLSBRIDGE, IE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ENDO OPERATIONS LIMITED
ENDO PHARMACEUTICALS INC.
DUPONT MERCK PHARMACEUTICAL COMPANY, THE
INTRAVENOUS PRODUCTS CO. OF AMERICA, INC.
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5Class 18
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
TABLETS FOR THE RELIEF OF PAIN
Publications
History of USPTO decisions and trademark events.
42 publications found
RNL6
REGISTERED AND RENEWED (SIXTH RENEWAL - 10 YRS)
08/19/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/19/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/19/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/28/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/04/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/04/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/25/2015
RNL5
REGISTERED AND RENEWED (FIFTH RENEWAL - 10 YRS)
09/25/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/25/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/25/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
08/27/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/26/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/26/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/26/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/12/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/20/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/15/2010
NOSU
NOTICE OF SUIT
04/24/2007
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
03/09/2006
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
12/29/2005
PLGL
ASSIGNED TO PARALEGAL
12/01/2005
AMD7
SEC 7 REQUEST FILED
09/15/2005
PAPER RECEIVED
09/15/2005
RNL4
REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
06/28/2005
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/28/2005
PLGL
ASSIGNED TO PARALEGAL
06/28/2005
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
06/01/2005
PAPER RECEIVED
06/01/2005
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
10/03/2003
15AF
REGISTERED - SEC. 15 AFFIDAVIT FILED
06/20/2003
PAPER RECEIVED
06/20/2003
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
07/25/1995
9.AF
REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
06/05/1995
XXXX
POST REGISTRATION ACTION CORRECTION
03/16/1990
CAND
CANCELLATION DENIED NO. 999999
01/09/1980
REN2
REGISTERED AND RENEWED (SECOND RENEWAL - 20 YRS)
06/04/1975
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/04/1954
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
11/02/1953
P12C
PUBLISHED SECTION 12(C)
07/27/1948
Continuous trademark protection
Get notified about every new filing that threatens ENDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.